Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 15Lymphoma, Non-Hodgkin 13Leukemia 11Hodgkin Disease 11Burkitt Lymphoma 10Leukemia, Biphenotypic, Acute 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Immunoblastic Lymphadenopathy 4Dendritic Cell Sarcoma, Interdigitating 4Neoplasms 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neurotoxicity Syndromes 2Neoplasm, Residual 2Leukemia, Lymphocytic, Chronic, B-Cell 2Enteropathy-Associated T-Cell Lymphoma 2Down Syndrome 2Vomiting 1Pulmonary Disease, Chronic Obstructive 1Philadelphia Chromosome 1

Interventions

Vincristine 4Radiotherapy 3Procarbazine 3Methotrexate 3Cytarabine 3Rituximab 2Prednisolone 2Cyclophosphamide 2motexafin gadolinium 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1Simvastatin 1Neuropsychological Tests 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Leucovorin 1Interleukin 1 Receptor Antagonist Protein 1Glutamine 1Glutamic Acid 1Etoposide 1Doxorubicin 1Dietary Supplements 1Dexamethasone 1Contrast Media 1Bendamustine Hydrochloride 1Baclofen 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Prednisolone × Lymphoid × Clear all
NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

University College, London

Phase 2 Completed
47 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT00991744 2012-10-10

Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

Nordic Society for Pediatric Hematology and Oncology

Phase 3 Suspended
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡